Clinical & translational oncology

• 

  Año 2016, Vol. 18, Número 7

  • Targeting the microenvironment of pancreatic cancer: overcoming treatment barriers and improving local immune responses

    J. Strauss, C. Alewine, W.D. Figg, A. Duffy

    • Resumen

    págs. 653-659

    

  • Long noncoding RNAs in lung cancer: what we know in 2015

    Y. J. Xu, Y. Du, Yun Fan

    • Resumen

    págs. 660-665

    

  • Further evidence for preoperative chemoradiotherapy and transanal endoscopic surgery (TEM) in T2-3s,N0,M0 rectal cancer

    Carles Pericay Pijaume, Xavier Serra Aracil, J. Ocaña Rojas, Laura Mora López, Emma Dotor Navarro, A. Casalots, Aleydis Pisa Gatell, Eugeni Saigí Grau

    • Resumen

    págs. 666-671

    

  • S-l combined with cisplatin plus concurrent chemoradiotherapy versus cisplatin plus concurrent chemoradiotherapy for Chinese patients with advanced gastric cancer: a multi-centre randomized controlled trial

    X. Chen, W. Li, L. Sun, Y. Liu, S. Liu, R. Ma

    • Resumen

    págs. 672-676

    

  • Compliance to radiation therapy of head and neck cancer patients and impact on treatment outcome

    B.C. Ferreira, Pedro Sá-Couto, M.C. Lopes, L. Khouri

    • Resumen

    págs. 677-684

    

  • A meta-analysis of abnormal β-catenin immunohistochemical expression as a prognostic factor in lung cancer: location is more important

    Y. Yang, J. Shen, Jiaxi He, Jianxing He, G. Jiang

    • Resumen

    págs. 685-692

    

  • Can tumor regression grade influence survival outcome in ypT3 rectal cancer?

    L. Shen, L. Wang, G. Li, H. Zhang, L. Liang, M. Fan, Y. Wu, W. Deng, W. Sheng, J. Zhu, Z. Zhang

    • Resumen

    págs. 693-699

    

  • CCR6 overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer

    X.G. Zhang, B.T. Song, F.J. Liu, D. Sun, K.X. Wang, H. Qu

    • Resumen

    págs. 700-707

    

  • Landscape of early clinical trials for childhood and adolescence cancer in Spain

    F. J. Bautista Sirvent, Soledad Gallego Melcón, María Adela Cañete Nieto, Jaume Mora Graupera, C. Díaz de Heredia Rubio, Ofelia Cruz Martínez, José María Fernández Navarro, S. Rives Solà, Luis Madero López, Victoria Castel Sánchez, M. E. Cela de Julián, Gemma Ramírez Villar, Constantino Sábado Alvarez, Tomás Acha García, Itziar Astigarraga Aguirre, Ana Sastre Urgellés, A. Muñoz Mellado, Mercedes Guibelalde del Castillo, Lucas Moreno

    • Resumen

    págs. 708-713

    

  • Clinical significance of cellular and acellular mucin pools in rectal carcinoma following preoperative chemoradiotherapy

    Javier Álvarez Cienfuegos Suárez, Jorge Baixauli Fons, Fernando Rotellar Sastre, Jorge Arredondo Chaves, Jesús J. Sola, Leire Arbea Moreno, Carlos Pastor Idoate, José Luis Hernández Lizoain

    • Resumen

    págs. 714-721

    

  • Overexpression of Cathepsin L is associated with gefitinib resistance in non-small cell lung cancer

    F. Cui, W. Wang, D. Wu, X. He, J. Wu, M. Wang

    • Resumen

    págs. 722-727

    

  • Clinical significance of TP53 (R72P) and MDM2 (T309G) polymorphisms in breast cancer patients

    P. Yadav, M. Masroor, K. Tanwer, R. Mir, J. Javid, I. Ahmad, M. Zuberi, R.C.M. Kaza, S. K. Jain, N. Khurana, P.C. Ray, A. Saxena

    • Resumen

    págs. 728-734

    

  • Clinical significance of ECT2 expression in tissue and serum of gastric cancer patients

    H.B. Wang, H.C. Yan, Y. Liu

    • Resumen

    págs. 735-742

    

  • Stereotactic body radiation therapy (SBRT) delays the emergence of castration resistance in patients with oligometastatic prostate cancer

    María Isabel Martínez Fernández, José Luis Pérez Gracia, Ignacio Gil-Bazo, Rafael Martínez Monge

    • Resumen

    págs. 743-747